Anosmia is the complete loss or absence of the sense of smell. This condition, though often overlooked, can significantly impact quality of life, as the olfactory sense is essential not only for detecting odors but also for enjoying food flavors, detecting hazards (like smoke or gas leaks), and contributing to emotional and social well-being. Anosmia may arise suddenly or gradually, and it can be either temporary or permanent depending on its underlying cause. 

Historically, the sense of smell has received less attention compared to vision and hearing. However, recent scientific advances and the emergence of conditions like COVID-19, where anosmia is a common symptom, have brought renewed focus to this important sensory function. This article provides a comprehensive overview of anosmia, covering its causes, pathophysiology, clinical features, diagnostic approach, treatment options, complications, and prognosis. 

Anosmia is defined as the complete inability to perceive odors. This distinguishes it from hyposmia, a partial loss of smell, and dysosmia, a distortion of smell perception. The loss may be unilateral (affecting one nostril) or bilateral (affecting both nostrils). The olfactory system includes the olfactory epithelium, olfactory nerve, olfactory bulb, and higher brain centers that process smell. Damage to any part of this pathway can result in anosmia. 

The sense of smell plays a critical role in the perception of flavor. Many people with anosmia report that food tastes bland or unappetizing. In addition, anosmia can compromise safety, as affected individuals may not detect spoiled food, gas leaks, or smoke. 

In addition to the profound impact on flavor perception, anosmia can also affect personal hygiene awareness, as individuals may not detect body odors or environmental smells that signal the need for cleaning or ventilation. Furthermore, the olfactory system is closely linked to the limbic system, which is involved in emotions and memory, explaining why anosmia can lead to emotional blunting or decreased ability to recall odor-associated memories. 

Anosmia can result from a wide range of conditions, broadly grouped into three categories: 

1.   Conductive (Obstructive) Causes 

These prevent odorants from reaching the olfactory epithelium: 

• Nasal polyps 
• Chronic rhinosinusitis 
• Allergic rhinitis 
• Deviated nasal septum 
• Nasal tumors 
• Foreign bodies (more common in children) 

2️. Sensorineural (Neurogenic) Causes 

These involve damage to the olfactory neuroepithelium, olfactory nerve, or central olfactory pathways: 

• Viral infections 
• Upper respiratory tract infections (including COVID-19) 
• Influenza 
• Head trauma 
• Shearing of the olfactory nerve fibers at the cribriform plate 
• Neurodegenerative diseases 
• Alzheimer’s disease 
• Parkinson’s disease 
• Huntington’s disease 
• Intracranial tumors 
• Meningiomas 
• Frontal lobe gliomas 
• Congenital conditions 
• Kallmann syndrome (anosmia with hypogonadotropic hypogonadism) 
• Toxic exposure 
• Prolonged exposure to chemicals (e.g., formaldehyde, solvents) 
• Radiation therapy to head and neck 

3️. Idiopathic 

In some cases, no cause is identified despite thorough evaluation. Idiopathic anosmia accounts for a notable proportion of cases, especially in older adults. 

Additional causes include medication-induced anosmia, where certain drugs such as intranasal zinc preparations, some antibiotics, and antihypertensives may impair olfactory function. Endocrine disorders, including hypothyroidism and diabetes, can also contribute to olfactory dysfunction. Rare autoimmune conditions like Sjögren’s syndrome may affect nasal mucosa, leading to dryness and subsequent anosmia. In elderly individuals, a gradual decline in olfactory function is common due to neuronal loss and reduced regenerative capacity of the olfactory epithelium. 

The sense of smell begins when odor molecules bind to olfactory receptors in the nasal cavity. These receptors send signals via the olfactory nerve to the olfactory bulb and then to higher centers in the brain. Anosmia can occur if: 

• Odor molecules are physically prevented from reaching receptors (conductive loss). 

• The receptors or olfactory nerve are damaged (sensorineural loss). 

• Brain areas responsible for processing smell are impaired. 

In post-viral anosmia, for example, viruses may directly damage the olfactory neuroepithelium. In head trauma, olfactory nerve fibers can be torn as they pass through the cribriform plate. In neurodegenerative diseases, loss of smell may result from damage to olfactory processing centers. 

Research indicates that the olfactory epithelium possesses a unique regenerative ability among sensory systems. However, persistent inflammation or direct viral cytopathic effects may lead to apoptosis of olfactory receptor neurons, preventing effective regeneration. Additionally, olfactory bulb volume has been correlated with olfactory function; decreased bulb volume observed via MRI in post-viral anosmia patients suggests a structural correlate of persistent smell loss. Neuroinflammation and disruption of synaptic connections within central olfactory pathways may also underlie anosmia in neurodegenerative diseases. 

Symptoms 

• Complete loss of smell perception. 

• Reduced ability to enjoy food flavors. 

• Unawareness of environmental odors (e.g., smoke, gas leaks). 

• In some cases, associated loss of taste (although true taste loss is rare; it’s usually loss of flavor due to absent smell). 

Impact on Quality of Life 

• Decreased appetite, weight loss. 

• Depression, anxiety, social withdrawal. 

• Safety concerns (failure to detect hazards). 

It is also notable that phantosmia (perception of odors that are not present) and parosmia (distorted odor perception) may occur during recovery phases of anosmia, particularly post-viral, and can be distressing to patients. These phenomena often indicate partial regeneration or reorganization of olfactory pathways. Some individuals with anosmia may also experience a reduction in quality of sleep, likely related to altered limbic and hypothalamic signaling secondary to loss of olfactory input. 

History 

• Onset (sudden or gradual) 

• Associated symptoms (nasal congestion, head injury, systemic illness) 

• Past medical history (sinonasal disease, neurodegenerative conditions) 

• Medication history 

• Occupational exposures 

Examination 

• Nasal endoscopy (to look for polyps, tumors) 

• Neurological examination 

Investigations 

• Olfactory testing 

• University of Pennsylvania Smell Identification Test (UPSIT) 

• Sniffin’ Sticks test 

• Imaging 

• MRI (especially in cases of trauma or suspected tumor) 

• CT scan (sinonasal disease evaluation) 

Smell testing should be systematic, and threshold tests can complement identification tests to evaluate the lowest concentration of an odor that can be detected. Comprehensive evaluation may include electro-olfactogram (EOG) testing to assess the function of the olfactory epithelium, although this is less commonly used in clinical settings. When central causes are suspected, neuropsychological assessments may help evaluate associated cognitive decline in neurodegenerative conditions presenting with anosmia. 

Differential Diagnosis 

• Hyposmia (partial smell loss) 

• Dysosmia (distorted smell perception) 

• Age-related decline in smell 

• Gustatory disorders (true taste loss) 

Consideration should also be given to psychogenic anosmia, where no organic cause is identified, and the anosmia is associated with psychological conditions such as depression or conversion disorder. Differentiating true anosmia from taste disorders requires careful history-taking, as many patients equate flavor loss with taste loss. 

Treat underlying cause 

• Nasal polyps or tumors: Surgery (polypectomy, tumor resection) 

• Chronic sinusitis: Medical therapy (nasal steroids, saline irrigation, antibiotics if needed) 

• Allergic rhinitis: Antihistamines, nasal steroids 

Supportive care 

• Safety measures (install smoke/gas detectors) 

• Dietary counseling to enhance food flavor perception 

• Psychological support 

Experimental therapies 

• Olfactory training (repeated exposure to odors to stimulate recovery) 

• Trials of corticosteroids (in select cases, e.g., post-viral anosmia) 

Emerging evidence supports the role of olfactory training, a structured exposure to a set of odors (typically rose, eucalyptus, lemon, and clove), repeated twice daily over several months, in enhancing recovery in post-infectious anosmia. The use of systemic corticosteroids remains controversial but may be trialed in select cases with evidence of inflammation. Nutritional counseling should focus on using spices and textures to improve food enjoyment, and patients should be advised on the use of alarms and sensors for fire and gas leak detection to enhance safety at home. 

Additionally, addressing mental health concerns is essential, as the chronic loss of smell can contribute to depressive symptoms, requiring psychological support or therapy. 

• Nutritional deficiencies (due to poor appetite) 

• Depression, social isolation 

• Increased risk of accidental harm (e.g., fire, gas exposure) 

Beyond nutritional and safety concerns, anosmia can negatively affect social relationships, as shared meals and sensory experiences are integral to social bonding. Individuals may avoid social situations due to the lack of enjoyment or fear of personal odor issues they cannot detect. 

• Post-viral anosmia: partial recovery in many cases over months. 

• Traumatic anosmia: often permanent. 

• Sinonasal causes: recovery possible with appropriate treatment. 

• Neurodegenerative causes: progressive, no recovery of smell. 

The prognosis of anosmia depends on the cause and duration of the condition before intervention. Early initiation of treatment for reversible causes is associated with better outcomes. Studies indicate that olfactory recovery in post-viral anosmia may continue over 12–24 months, and the presence of parosmia during recovery may suggest a favorable prognosis. 

• Prompt treatment of nasal and sinus infections. 

• Use of protective equipment to avoid head injury. 

• Avoidance of toxic exposures. 

Additional preventive strategies include the use of protective headgear in high-risk activities to prevent traumatic brain injury, and the adoption of vaccination strategies (e.g., influenza, COVID-19) to reduce the risk of post-viral anosmia. 

Anosmia is a common but often under-recognized disorder that can have profound effects on health and well-being. Timely identification of the underlying cause and appropriate intervention are essential to improve outcomes. Continued research into regenerative therapies and olfactory training holds promise for the future. 

A comprehensive, multidisciplinary approach is critical for managing anosmia, encompassing medical treatment, safety adaptation, nutritional counseling, and psychological support. As research advances, therapies such as stem cell transplantation and molecular regenerative therapies are being investigated to restore olfactory function in cases of permanent anosmia, offering hope for individuals affected by this condition in the future. 

1. Doty RL. Olfaction. Annu Rev Psychol. 2001;52:423-452. 

2. Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54(26):1-30. 

3. Leopold DA. Distortion of olfactory perception: diagnosis and treatment. Chem Senses. 2002;27(7):611-615. 

4. Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life—an updated review. Chem Senses. 2014;39(3):185-194.